Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 31
Item hits:
Issue DateTitleAuthor(s)
23-Sep-2016Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patientsFlanagan, JM; Wilson, A; Koo, C; Masrour, N; Gallon, J, et al
21-Dec-2016Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.Wilhelm-Benartzi, CS; Mt-Isa, S; Fiorentino, F; Brown, R; Ashby, D, et al
20-May-2015Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).Brown, R; Timms, K; Paul, J; Hughes, E; El-Bahrawy, M, et al
2-Aug-2015Transcriptional implications of intragenic DNA methylation in the estrogen receptor alpha gene in breast cancer cells and tissuesShenker, NS; Flower, KJ; Wilhelm-Benartzi, C; Dai, W; Bell, E, et al
1-Jan-2015Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study.Flanagan, JM; Brook, MN; Orr, N; Tomczyk, K; Coulson, P, et al
1-May-2015Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.Shenker, NS; Flower, KJ; Wilhelm-Benartzi, CS; Dai, W; Bell, E, et al
4-Jan-2016DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.Flower, KJ; Shenker, NS; El-Bahrawy, M; Goldgar, DE; Parsons, MT, et al
10-Oct-2013Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patientsFlanagan, JM; Wilhelm-Benartzi, CS; Metcalf, M; Kaye, SB; Brown, R
28-Mar-2017Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre studyPhelps, DL; Borley, J; Flower, K; Dina, R; Darb-Esfahani, S, et al
13-Jan-2016Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.Bonito, NA; Borley, J; Wilhelm-Benartzi, CS; Ghaem-Maghami, S; Brown, R, et al